Yahoo Finance

NeuroSigma Announces Commercial Launch of The Monarch eTNS® System for the Treatment of Pediatric ADHD at Annual Meeting of the American Academy of Child and Adolescent Psychiatry

LOS ANGELES, Oct. 17, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, today announced the commercial launch of The Monarch eTNS System at the annual meeting of ...
Yahoo Finance

NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA

LOS ANGELES, April 30, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for ...
Companies

New Monarch monitoring system for circular knitting

Monarch, a UK supplier of high-end circular knitting machines, has joined forces with Belgium-based BMSvision to develop and install a new monitoring system for real-time analysis of all production ...
Healio

FDA clears second-generation Monarch eTNS System for treating pediatric ADHD

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the use of NeuroSigma’s second-generation Monarch eTNS System for treating pediatric ADHD. The ...